BiomaLearnFoodsNutrientsGuidesAnswersEvidence

Butter or peanut butter: the swap nobody has tested

Nobody has put butter and peanut butter side by side in a trial or a cohort. Our search found none. What exists is a set of comparisons that each stop one step short of the question. Butter has been measured against oils. Across 54 feeding trials of at least three weeks, moving 10 percent of daily energy from butter to any of nine plant oils, or even to beef fat, lowered LDL cholesterol by 0.23 to 0.42 mmol/L, or about 9 to 16 mg/dL on a US test. Butter finished last for LDL of everything tested. In 221,054 US health professionals followed for up to 33 years, replacing 10 g of butter a day with the same weight of plant oil went with a 17 percent lower death rate. That is an association in people already eating that way. Neither study used peanut butter. On its own, butter is a weaker story: across 636,151 people, each tablespoon a day was tied to a 1 percent higher death rate, no change in cardiovascular disease and 4 percent lower diabetes, with no randomised trial behind any of it. Those cohorts asked only what happens as butter goes up, with no statement about what goes down to make room for it. The number you get for butter depends on what you compare it with. Peanut butter has its own evidence, and it is thinner. Pooled cohorts tie it to 13 percent lower type 2 diabetes incidence, a result the authors themselves grade as very low certainty. In 120,852 Dutch adults, 10 g or more of nuts a day went with 23 percent lower mortality while peanut butter showed no link at all. The EU refused a label claim that two tablespoons a day help with cholesterol and heart health. So the case for the swap rests on oils and whole nuts standing in for peanut butter, and the one large study that looked at peanut butter by itself found nothing. Every number here comes from the food as people eat it, and a tablespoon is 16 g of peanut butter but 14 g of butter.

Every statement here is tied to a source. The badge says what kind of evidence stands behind it: A is a meta-analysis or systematic review, E is the position of an expert body without its own analysis. How we verify →

We have no USDA entry for butter | peanut butter itself in this cohort. The evidence below stands on published studies rather than on a composition table, and we would rather say that than show you a number for something else.

What a real portion looks like

What your body absorbs

What cooking and storage change

What it does to your health

Safety, limits and interactions

What people believe that the data does not support

Who this works differently for

The bottom line

If you are choosing for your cholesterol, the trials point away from butter and towards plant oil, and peanut butter was not the thing they poured in its place. If you want peanut butter anyway, here is what has been measured on it. Grinding peanuts releases their fat. On a high-fibre diet 17.8 percent of dietary fat left in the stool after whole peanuts against 7.0 percent after peanut butter, in one 1980 feeding study quoted inside a 2023 review, so more of the fat in the jar reaches you than the same peanuts whole would give. That did not show up on the scales in the one trial that tried. In 118 adults, 56 g a day of peanuts as raw, roasted, salted, honey roasted or as peanut butter for four weeks made no difference to weight or fasting lipids between the forms. Lipids improved only in the people who started high. In 120 Australians over 65, 43 g a day for six months changed neither weight nor fat mass, and gait speed, the measure the trial set out to change, did not move either. What did move was getting out of a chair five times, 1.2 seconds faster, and muscle power by 22 W, in a trial run open-label against usual care. The finding that peanut butter at breakfast blunted the glucose rise after lunch and the urge to eat comes from 15 obese women over a single day of sampling. It is a mechanism worth knowing and too small to plan a diet on. Watch the portion. On a slice of bread the usual spread is 16 g of peanut butter against 7 g of butter, more than twice the weight, so a swap on toast is a swap of amount as well as of food. None of this is for anyone with a peanut allergy. The one trial in highly allergic children tested a minute of touching and ten minutes of smelling, and 0 of 30 had a systemic or breathing reaction, with local redness or itch in 10. It says nothing about eating. A review of Iranian peanut products found aflatoxin B1, a mould toxin, at levels its own authors read as a chance of a cancer risk. We have no card on peanuts sold anywhere else, so we cannot tell you how your jar compares. One more gap is ours. No card under this page says who should limit either spread or by how much, nothing on pregnancy, on young children, on salt, on any drug. Read that as unanswered rather than as safe.

Sources

  1. bpb-c1-14 · reference dataset
    FNDDS 2707537 Peanut butter — 1 tablespoon 16 g · Guideline amount per slice of bread/roll 16 g · Guideline amount per sandwich 32 g · FNDDS 2710155 Butter, stick — 1 tablespoon 14 g · 1 pat 7 g · Guideline amount per slice of bread/roll 7 g
    USDA FNDDS 2021-2023 · checked 2026-09-23
  2. bpb-c1-07 · randomised crossover clinical trial
    A group of fifteen women participated in a randomised cross-over clinical trial in which 42·5 g of whole peanuts without skins (WP), peanut butter (PB) or no peanuts (control) were added to a 75 g available carbohydrate-matched breakfast meal. ... Postprandial NEFA incremental AUC (IAUC) (0-240 min) and glucose IAUC (240-490 min) responses were lower for the PB breakfast compared with the control breakfast. ... WP led to similar but non-significant effects. ... The greater bioaccessibility of the lipid component in PB is probably responsible for the observed incremental post-ingestive responses between the nut forms.
    Br J Nutr, 2013 · checked 2026-09-23
  3. bpb-c1-09 · systematic review with narrative synthesis of human feeding studies and in vitro studies
    A high-fiber diet showed more dietary fat in the feces after consumption of whole peanuts (17.8%) and peanut butter (7.0%) than a low-fiber diet (whole peanuts: 16.8%; peanut butter: 4.2%) [37].
    Adv Nutr, 2023 · checked 2026-09-23
  4. bpb-c1-08 · multicentre randomised controlled trial
    One hundred and eighteen adults (forty-seven males and seventy-one females; age 29.2 (sd 8.4) years; BMI 30.0 (sd 4.5) kg/m2) from Brazil, Ghana and the United States were randomised to consume 56 g of raw unsalted (n 23), roasted unsalted (n 24), roasted salted (n 23) or honey roasted (n 24) peanuts, or peanut butter (n 24) daily for 4 weeks. Peanut form and processing did not differentially affect body weight or fasting plasma lipid responses in the total sample.
    Br J Nutr, 2010 · checked 2026-09-23
  5. bpb-c1-01 · systematic review and network meta-analysis of randomised trials
    Each 10% of dietary energy from butter replaced with an equivalent amount of safflower, sunflower, rapeseed, flaxseed, corn, olive, soybean, palm, and coconut oil, and beef fat was more effective in reducing LDL-C (−0.42 to −0.23 mmol/l).
    J Lipid Res, 2018 · checked 2026-09-23
  6. bpb-c1-03 · prospective cohort study, substitution analysis
    Substituting 10-g/d intake of total butter with an equivalent amount of total plant-based oils was associated with an estimated 17% reduction in total mortality (HR, 0.83; 95% CI, 0.79-0.86; P < .001) and a 17% reduction in cancer mortality (HR, 0.83; 95% CI, 0.76-0.90; P < .001).
    JAMA Intern Med, 2025 · checked 2026-09-23
  7. bpb-c1-04 · systematic review and meta-analysis of prospective cohort studies with GRADE
    There was moderate CoE for a lower risk of CVD when substituting processed meat with nuts [SHR (95% CI): 0.73 (0.59, 0.91), n = 8 cohorts] ... and butter with olive oil [0.96 (0.95, 0.98), n = 3]. ... dairy with nuts [0.94 (0.91, 0.97), n = 3]
    BMC Med, 2023 · checked 2026-09-23
  8. bpb-c1-06 · systematic review and meta-analysis of observational studies
    Meta-analyses of prospective cohort studies showed an inverse association between peanut butter consumption and T2D incidence (RR: 0.87; 95% CI: 0.77, 0.98; I2 = 50.6%; Pheterogeneity = 0.16), whereas no association was observed between peanuts or tree nuts and T2D. ... The certainty of the evidence using NutriGrade was very low for all the exposures.
    Am J Clin Nutr, 2021 · checked 2026-09-23
  9. bpb-c1-11 · double-blind, placebo-controlled randomised exposure challenge
    Thirty children underwent the challenges (median age, 7.7 years; median peanut IgE level, >100 kIU/L; 13 with prior history of contact and 11 with inhalation reactions). None experienced a systemic or respiratory reaction. Erythema (3 subjects), pruritus without erythema (5 subjects), and wheal-and-flare reactions (2 subjects) developed only at the site of skin contact with peanut butter.
    J Allergy Clin Immunol, 2003 · checked 2026-09-23
  10. bpb-c1-12 · systematic review of food contamination surveys
    The contamination of AFB1 in peanut was high in Mashhad and Tehran compared with the other cities. The value of MOE was calculated less than 10,000. The results of MOE indicate that there are chances of the risk of developing cancer and these products may not be safe.
    Rev Environ Health, 2022 · checked 2026-09-23
  11. bpb-c1-02 · systematic review and meta-analysis of prospective cohort studies
    No RCTs were identified. Butter consumption was weakly associated with all-cause mortality (N = 9 country-specific cohorts; per 14g(1 tablespoon)/day: RR = 1.01, 95%CI = 1.00, 1.03, P = 0.045); was not significantly associated with any cardiovascular disease (N = 4; RR = 1.00, 95%CI = 0.98, 1.02; P = 0.704) ... and was inversely associated with incidence of diabetes (N = 11; RR = 0.96, 95%CI = 0.93, 0.99; P = 0.021).
    PLoS One, 2016 · checked 2026-09-23
  12. bpb-c1-05 · prospective cohort study with meta-analysis of cohorts
    When comparing those consuming 0.1-<5, 5-<10 and 10+ g nuts/day with non-consumers, multivariable hazard ratios for total mortality were 0.88, 0.74 and 0.77 [95% confidence interval (CI), 0.66-0.89], respectively (Ptrend = 0.003). ... Peanuts and tree nuts were inversely related to mortality, whereas peanut butter was not.
    Int J Epidemiol, 2015 · checked 2026-09-23
  13. bpb-c1-13 · regulatory register entry
    POL-HC-7733 Peanuts, Peanut butter, Peanut oil Consuming a small handful, about 30 grams, of peanuts a day as part of a diet low in saturated fat helps to achieve healthy cholesterol levels and promotes heart health. Consuming two tablespoons, about 30g, of peanut butter a day as part of a diet low in saturated fat helps to achieve healthy cholesterol levels and promotes heart health. Consuming two tablespoons, about 30 grams of peanut oil a day as part of a diet low in saturated fat helps to achieve healthy cholesterol levels and promotes heart health. Non-authorised
    EU Register on nutrition and health claims, claim POL-HC-7733, snapshot 2026-09-21 · checked 2026-09-23
  14. bpb-c1-10 · randomised controlled trial, usual care control
    One hundred and twenty older adults (aged ≥ 65 years) at risk of falls were randomly assigned to receive peanut butter (43 g/day, n = 60) or maintain usual care (control, n = 60) for 6 months. ... At 6 months, there were no significant treatment effects on the primary outcome of gait speed or other measures of physical function (p > 0.05), with the exception that 5STS time and muscle power improved significantly more in the peanut butter compared to control group (estimated treatment effect: time, -1.23 s [95% CI, -2.09, -0.37], p = 0.006; absolute power, 22.0 W [95% CI: 7.1 to 36.9], p = 0.004; relative power, 0.27 W/kg [95% CI: 0.10 to 0.45], p = 0.002). Changes in HGS, KES, weight, BMI, total fat mass, total lean mass or appendicular lean mass did not differ between groups.
    J Cachexia Sarcopenia Muscle, 2026 · checked 2026-09-23

Review. Reviewed on 2026-09-24 for evidence level, dose and population context, and claims a reader could misread. Bioma Learn has no human medical reviewer at this time, and we say so rather than invent one. Methodology. This is information, not medical advice.